Photo for representational purpose only.
New Delhi, May 29
The Singapore Supreme Court has dismissed an appeal by erstwhile Ranbaxy Laboratories’ former promoters Malvinder Singh and Shivinder Singh against a high court order that declined to set aside an arbitration award in favour of Japan’s Daichii Sankyo.
Confirming the development, Anand Pathak, Managing Partner P&A Law Offices, representing Japanese pharma firm Daaichi Sankyo said, “The Singapore Supreme Court has dismissed the appeal.” He further said, "We have been trying to enforce the award and we will continue in a very focused way to enforce the award, now that there is a finality to the appeal." With interests and everything, the total amount is in excess of Rs 3,500 crore, Pathak said. — PTI
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
People of India have given clear mandate for third time: President Murmu in Parliament
Congratulates newly elected members of 18th Lok Sabha
Looking forward to the results of India's inquiry into Pannun case: US
In November last year, US federal prosecutors charged Indian...
Increase in anti-conversion laws, hate speech for minorities in India concerning: Antony Blinken
His remarks come at the release of the annual State Departme...
AAP to boycott President’s address to Parliament to protest against Kejriwal’s arrest
AAP general secretary (organisation) and Rajya Sabha MP Sand...
South Africa defeat Afghanistan by 9 wickets, enter maiden T20 World Cup final
They will face the winners of the second semifinal between I...
